GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing SL Pharmaceutical Co Ltd (SZSE:002038) » Definitions » Inventories, Raw Materials & Components

Beijing SL Pharmaceutical Co (SZSE:002038) Inventories, Raw Materials & Components : ¥0.0 Mil (As of Sep. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Beijing SL Pharmaceutical Co Inventories, Raw Materials & Components?

Beijing SL Pharmaceutical Co's inventories, raw materials & components for the quarter that ended in Sep. 2024 was ¥0.0 Mil.

Beijing SL Pharmaceutical Co's quarterly raw materials increased from Mar. 2024 (¥0.0 Mil) to Jun. 2024 (¥140.3 Mil) but then declined from Jun. 2024 (¥140.3 Mil) to Sep. 2024 (¥0.0 Mil).

Beijing SL Pharmaceutical Co's annual raw materials increased from Dec. 2021 (¥107.2 Mil) to Dec. 2022 (¥114.8 Mil) and increased from Dec. 2022 (¥114.8 Mil) to Dec. 2023 (¥118.2 Mil).


Beijing SL Pharmaceutical Co Inventories, Raw Materials & Components Historical Data

The historical data trend for Beijing SL Pharmaceutical Co's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing SL Pharmaceutical Co Inventories, Raw Materials & Components Chart

Beijing SL Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 82.19 96.50 107.23 114.84 118.20

Beijing SL Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 118.20 - 140.26 -

Beijing SL Pharmaceutical Co Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Beijing SL Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No.69 Fu shi Road, No.1 Building, Bitongyuan, Haidian district, Beijing, CHN, 100049
Beijing SL Pharmaceutical Co Ltd is a Chinese biotechnology-pharmaceutical company. It is principally focused on developing and marketing gene engineering drugs. The product portfolio of the company includes drugs for Oncology, Hepatopathy and Senile disease. Its products include Filgrastim, Asparaginase, Dasartinib, Enoxaparin, Naftopidil, Ademetionine, Lenalidomide, and others.
Executives
Liang Shu Jie Secretary, Director
Xu Ming Bo Directors, executives
Yang Zhong Fan Supervisors
Chen Yu Lin Director
Qi Yan Ming Supervisors
Xi Wen Ying Executives
Wu Yan Zhuo Executives
Wang Wen Xin Director
Li Ya Jun Executives
Zhao Xia Securities Affairs Representative
Zhang Chun Lei Supervisors
Wang Yong Bo Directors, executives
Lu An Jing Supervisors
Wei Su Yan Director

Beijing SL Pharmaceutical Co Headlines

No Headlines